<DOC>
	<DOCNO>NCT00542009</DOCNO>
	<brief_summary>Study whether investigational drug CE-326,597 improve glucose control result body weight loss patient type 2 diabetes</brief_summary>
	<brief_title>A Trial In Diabetic Patients To Assess Effect Of CE-326,597 On Glucose Control And Body Weight</brief_title>
	<detailed_description />
	<mesh_term>Body Weight</mesh_term>
	<criteria>Patients type 2 diabetes , oral ( 2 ) antidiabetic medication , otherwise medically stable . Women childbearing potential , people unstable medical condition , people gallstone</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>Phase 2A , safety efficacy trial CE-326,597 patient T2DM .</keyword>
</DOC>